Biochemical and clinical changes resulting from administration of marsilid and tryptophan to schizophrenic patients; biochemical aspects.
D006801:Humans; D009525:Niacin; D009539:Nicotinic Acids / Q000494:pharmacology*; D012559:Schizophrenia / Q000378:metabolism*; D014364:Tryptophan / Q000378:metabolism*
D009539:Nicotinic Acids; D009525:Niacin; D014364:Tryptophan
NICOTINIC ACID ISOMERS/effects; SCHIZOPHRENIA/metabolism; TRYPTOPHAN/metabolism